Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Possibly Marketed Outside US

5

US Previously Marketed

1

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

adrenergic receptor signaling pathway

1

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

6

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

Unknown

5

1949

1

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Muscle spasm

4

Amebiasis

1

Hypertension

1

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

5

Curative

1

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Knoll

4

Daiichi Seiyaku

1

Sanofi-Aventis

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

6

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

6

FDA UNII

6

PUBCHEM

6

ECHA (EC/EINECS)

4

EPA CompTox

4

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

ANTIPROTOZOALS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Arsenic compounds

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

3

Salts, Hydrates, Esters, etc.

3

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 6 of 6 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

GLYCOBIARSOL

E3U8347QWJ

Export Data
Search for Structure

Status:

US Previously Marketed

First approved in 1949

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Glycobiarsol was known under the brand name Milibis. Glycobiarsol is found to be very effective in intestinal infections. Milibis is an antiprotozoal agent that has been used in humans as well as in dogs.

BUDRALAZINE

S0177QHV2B

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

adrenergic receptor signaling pathway

Conditions:

Budralazine is a vasodilator. Budralazine is a direct-acting vasodilating agent that does not produce marked tachycardia. Hypotensive effect of Buterazine has being shown. Budralazine is reported as an ingredient of Buterazine in Japan.

OCTAMYLAMINE

S0737084O9

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

Class (Stereo):

CHEMICAL (RACEMIC)

Conditions:

Octamylamine is an Antispasmodic. Trademark: Octinum D.

OCTAMYLAMINE MUCATE

L9S34T2T2J

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

Class (Stereo):

CHEMICAL (MIXED)

Conditions:

Octamylamine is an Antispasmodic. Trademark: Octinum D.

OCTAMYLAMINE SULFAMATE

778333NHPO

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

Class (Stereo):

CHEMICAL (RACEMIC)

Conditions:

Octamylamine is an Antispasmodic. Trademark: Octinum D.

OCTAMYLAMINE HYDROCHLORIDE

69H8F4TGMI

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

Class (Stereo):

CHEMICAL (RACEMIC)

Conditions:

Octamylamine is an Antispasmodic. Trademark: Octinum D.

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1